Cardiac arrest & resuscitation

Continuous deep sedation versus minimal sedation after cardiac arrest and resuscitation (SED‐CARE): A protocol for a randomized clinical trial

Acta Anaesthesiol ScandPublished Protocol for a randomised controlled trial

Study context

Population
Adults comatose after resuscitation from out-of-hospital cardiac arrest (OHCA) with sustained return of spontaneous circulation (ROSC), randomised within 4 hoursplanned enrolment
Participants
3,500 participants
Planned comparison
Continuous deep sedation vs minimal sedation for 36 h after ROSC
Primary endpoint
All-cause mortality
Follow-up
6 months after randomization
Methodological details2 × 2 × 2 factorial, international, multicentre, parallel-group, investigator-initiated, superiority, Neurological prognostication per ERC and ESICM guidelines by a physician blinded to allocation, Sample size: 3500 to detect an absolute risk reduction of 5.6% (alpha 0.05, 90% power), Secondary outcomes: poor functional outcome at 6 months, serious adverse events in the ICU, patient-reported overall health status at 6 months
  • 2 × 2 × 2 factorial
  • International
  • Multicentre
  • Parallel-group
  • Investigator-initiated
  • Superiority
  • Neurological prognostication per ERC and ESICM guidelines by a physician blinded to allocation
  • Sample size: 3500 to detect an absolute risk reduction of 5.6% (alpha 0.05, 90% power)
  • Secondary outcomes: poor functional outcome at 6 months, serious adverse events in the ICU, patient-reported overall health status at 6 months

No results yet. This paper sets out the design of a trial; its results are to come.

Original publication

Continuous deep sedation versus minimal sedation after cardiac arrest and resuscitation (SED‐CARE): A protocol for a randomized clinical trial. Acta Anaesthesiol Scand. Published 3 April 2025. doi:10.1111/aas.70022

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.